Episode

Neuro-Oncology Nugget: Bivalent EGFR/IL13Rα2 CAR T Cells for Recurrent Glioblastoma

Podcast: Neuro-Oncology: The Podcast
Published: Apr 13, 2026
Duration seconds: 149
Processing state: not_requested
Canonical source: https://soc-neuro-onc.libsyn.com/neuro-oncology-nugget-bivalent-egfril13r2-car-t-cells-for-recurrent-glioblastoma
Audio: https://traffic.libsyn.com/secure/soc-neuro-onc/nop-127-.mp3?dest-id=2339594
JSON: /v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-bivalent-egfr-il13r-2-car-t-cells-for-recurrent-glioblastoma
Markdown: /podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-bivalent-egfr-il13r-2-car-t-cells-for-recurrent-glioblastoma.md

Actions

POST https://stenobird.com/v1/public/podcasts/neuro-oncology-the-podcast-1565653/episodes/neuro-oncology-nugget-bivalent-egfr-il13r-2-car-t-cells-for-recurrent-glioblastoma/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/neuro-oncology-the-podcast-1565653/neuro-oncology-nugget-bivalent-egfr-il13r-2-car-t-cells-for-recurrent-glioblastoma.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Shahad Abdulsahib discusses a phase 1 clinical trial of intracerebroventricular bivalent EGFR and IL13Rα2 CAR T cells for recurrent glioblastoma, published in Nature Medicine .